GCM
AGN

Geneva Capital Management’s Allergan Inc AGN Stock Holding History

Geneva Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-6,363
Closed -$1.08M – 134
2014
Q2 		$1.08M Sell
6,363
-5,654
-47% -$880K 0.03% 129
2014
Q1 		$1.49M Buy
12,017
+1,408
+13% +$171K 0.03% 108
2013
Q4 		$1.18M Buy
10,609
+60
+0.6% +$5.73K 0.03% 127
2013
Q3 		$954K Buy
10,549
+283
+3% +$25.4K 0.02% 130
2013
Q2 		$865K Buy
+10,266
New +$1.07M 0.02% 136

Other funds holding AGN

PSCM
Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geneva Capital Management's AGN Position: Q3 2014 in Review

Geneva Capital Management sold out of Allergan Inc (AGN) in Q3 2014, closing a stake of 6,363 shares — an estimated $1.08M sold.

Geneva Capital Management first reported a position in AGN in Q2 2013 and held it in 5 quarters. The position peaked at $1.49M in Q1 2014. 749 funds tracked by Wall St. Rank hold AGN as of Q3 2014.

  • Geneva Capital Management reported no remaining Allergan Inc position as of Q3 2014 after selling out during the quarter.
  • Geneva Capital Management sold 6,363 Allergan Inc shares in Q3 2014, an estimated $1.08M.
  • Geneva Capital Management first reported a position in Allergan Inc in Q2 2013 and held it in 5 quarters.
  • Geneva Capital Management's Allergan Inc position peaked at $1.49M in Q1 2014.
  • 749 funds tracked by Wall St. Rank held Allergan Inc as of Q3 2014.

Based on Geneva Capital Management's 13F filing for Q3 2014, filed 14 Nov 2014.